Seeking Alpha
01 Jul 2026, 15:05 UTC · 11w ago
Verdict
Headline leans bullish. We score TMDX +0.60 across three claims.
Score confirms the headline.
Leans bullish
From its wording — no explicit rating
+0.60strongly bullish
What the story claims
3 claims · scored −1 bearish … +1 bullish
TransMedics' Q1 gross margin fell to 58.2% and adjusted EPS dropped to $0.30.
More negative than 92% of claims this week
Q1 revenue grew 21% to $173.9M.
Continue reading
5 related stories
More positive than 74% of ticker scores this week
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More positive than 76% of claims this week
The company is building an integrated transplantation network to establish long-term market dominance.
So whatThe creation of a competitive moat suggests sustainable future pricing power and market share.
More positive than 64% of claims this week
Which stocks this story touches
More positive than 74% of ticker scores this week
The article maintains a Buy rating and emphasizes a strong long-term growth thesis and moat despite short-term margin pressure.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
18h ago
+31.3%
Price agrees with the score
$87.20 vs $66.42 close before publication (Jun 30) · not market-adjusted
TMDX chart →
